March 28, 2013
/PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Diabetes Landscape: Market, Technology and Intellectual Property
There are as many as 183 million people unaware that they have diabetes, including at least 78% of people with diabetes in
. In some of the poorest regions in the world, where infectious diseases have traditionally been the focus of healthcare systems, diabetes cases are expected to increase by 90% by 2030.
While most of the increase in diabetes prevalence is associated with the Type 2 form, the IDF also estimates there is a 3% increase annually in Type 1 diabetes in children aged under 15. Its data show there were 490,100 children in this age group globally with the condition in 2011 and the number of cases is rising by 77,800 annually.
The human cost
According to the World Health Organisation, 50% of people with diabetes die of cardiovascular disease, primarily heart disease or stroke. After 15 years of diabetes, approximately 2% of people become blind and about 10% develop severe visual impairment. In addition, 10 to 20% die of kidney failure, while diabetic neuropathy affects up to 50% of people with diabetes.
A global challenge
Although seen as a problem mainly affecting Western countries, in fact, 80% of people with diabetes live in low and middle income countries. The IDF estimates that the Western Pacific Region had the highest number of people with diabetes aged 20 to 79 years, at 132 million, while the African Region had the smallest number, at 15 million in 2011. However, the region with the highest comparative prevalence was the
, at 11%, followed by the
and Caribbean Region, at 10.7%. Prevalence in the Western Pacific Region was significantly lower, at 8.3%, while prevalence in the
region was 6.7%, representing the lowest after
Monitoring and treatment – critical components in disease management
Successful diabetes management is dependent on being able to accurately monitor blood glucose levels. That requires a range of both clinician and patient devices that are accurate, reliable and convenient. In addition, products that enable simple and convenient insulin delivery are needed by the quarter of diabetes patients that are insulin-dependent. The burgeoning diabetes burden represents a fast growing market place for companies who can supply those products.
"Who owns the rights to this technology? What trends are emerging? These and other questions are answered in this unmatched 2-volume report. Published by Espicom and UBM TechInsights, the report brings together their expertise to produce a study of insight and value."